Pinnacle IVD has announced the addition of the CovID Rapid Antigen Detection Test (RAD) to its current diagnostic test product line, which includes the Pinnacle CovID NEO IgG/IgM Antibody Test (NEO) and the second generation FIT Colon Cancer Test. The RAD is claimed to be one of the first point of care antigen tests that does not need additional laboratory equipment and provides accurate results in just 15 minutes. The firm has notified the US FDA through pre EUA format that it plans to submit an emergency use authorisation (EUA) within 10 days.
BASE10 Genetics has announced the results of an independent study that found 95% sensitivity and 100% specificity for SARS-Co-V-2 IgG antibodies using AccuFind COVID19 IgG test by DNA Link. This study was carried out at John Hopkins University. BASE10 provides a Covid-19 Tracking and Recovery Program that helps employers in introducing testing and monitoring strategies for Covid-19. The firm has been working to include antibody testing to monitor the full life cycle of SAR-Co-V-2.
Todos Medical, an in vitro diagnostics company, has entered into a Covid-19 testing and tracing partnership with Israel-based Pangea. Todos will be the preferred supplier of Covid-19 testing products for Pangea’s suite of offerings aimed at delivering contact tracing and ‘Covid testing passport’ services in Israel and some African countries. Todos will also be able to integrate and tailor Pangea’s technology offering into its services package in the US, Canada and Mexico in order to deliver a full solution for Covid-19 testing and contact tracing in a HIPAA compliant, ‘opt-in’ privacy tailored manner.
Biohit Healthcare's antibody and antigen tests for Covid-19 have received approval from Brazil's Ministry of Health. The firm’s Sars-CoV-2 IgM/IgG antibody test and SARS-CoV-2 Antigen quantitative assay kit are now included in the select group of Covid-19 tests of allowed manufacturers of goods in Brazil.